80 related articles for article (PubMed ID: 10490831)
1. Overexpression of the Tpl-2/Cot oncogene in human breast cancer.
Sourvinos G; Tsatsanis C; Spandidos DA
Oncogene; 1999 Sep; 18(35):4968-73. PubMed ID: 10490831
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.
Erny KM; Peli J; Lambert JF; Muller V; Diggelmann H
Oncogene; 1996 Nov; 13(9):2015-20. PubMed ID: 8934549
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
5. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
[TBL] [Abstract][Full Text] [Related]
8. Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas.
Leighton X; Srikantan V; Pollard HB; Sukumar S; Srivastava M
Cancer Lett; 2004 Jul; 210(2):239-44. PubMed ID: 15183540
[TBL] [Abstract][Full Text] [Related]
9. Detailed chromosomal characterization of the breast cancer cell line MCF7 with special focus on the expression of the serine-threonine kinase 15.
Klein A; Jung V; Zang KD; Henn W; Montenarh M; Kartarius S; Steudel WI; Urbschat S
Oncol Rep; 2005 Jul; 14(1):23-31. PubMed ID: 15944763
[TBL] [Abstract][Full Text] [Related]
10. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Tpl2/Cot oncogene in human T-cell neoplasias.
Christoforidou AV; Papadaki HA; Margioris AN; Eliopoulos GD; Tsatsanis C
Mol Cancer; 2004 Dec; 3(1):34. PubMed ID: 15575964
[TBL] [Abstract][Full Text] [Related]
13. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.
Sen S; Zhou H; White RA
Oncogene; 1997 May; 14(18):2195-200. PubMed ID: 9174055
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
[TBL] [Abstract][Full Text] [Related]
15. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
16. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E
Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430
[No Abstract] [Full Text] [Related]
17. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.
Choschzick M; Lebeau A; Marx AH; Tharun L; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Simon R; Sauter G; Schwarz J
Hum Pathol; 2010 Mar; 41(3):358-65. PubMed ID: 19896697
[TBL] [Abstract][Full Text] [Related]
18. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
Imyanitov EN; Chernitsa OI; Serova OM; Nikoforova IF; Pluzhnikova GF; Knyazev PG
Neoplasma; 1993; 40(1):35-9. PubMed ID: 7688867
[TBL] [Abstract][Full Text] [Related]
19. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
Ramírez de Molina A; Gutiérrez R; Ramos MA; Silva JM; Silva J; Bonilla F; Sánchez JJ; Lacal JC
Oncogene; 2002 Jun; 21(27):4317-22. PubMed ID: 12082619
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation.
Patriotis C; Makris A; Bear SE; Tsichlis PN
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2251-5. PubMed ID: 7681591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
